From The Editor
-
From BPI West: A Roundtable Discussion On Continuous Manufacturing
4/14/2025
Process Development experts share their thoughts on continuous manufacturing at this year's BPI West, touching on its benefits and present barriers to adoption.
-
From BPI West: Key Challenges And Benefits Of Continuous Manufacturing
4/7/2025
Continuous manufacturing was a hot topic of conversation at this year's BPI West. AstraZeneca's Ken Lee, Ph.D., weighs in during an exclusive interview with Bioprocess Online.
-
From BPI West: An Upstream Scientist's Advice On Target Glycosylation
4/1/2025
Bioprocess Online spoke to an upstream scientist at Bristol Myers Squibb during this year's BPI West. Here's what he had to say.
-
2025 Cell Therapy Outlook From BPI West
3/31/2025
Bioprocess Online and Cell & Gene spoke with Takeda’s Amy Shaw at BPI West to discuss the industry and her key takeaways from the conference.
-
Using AI And ML To Gain Insight Into Optimal Glycoforms
3/28/2025
Bioprocess Online asked Nathan Lewis, Ph.D., to briefly explain the research he presented at BPI West 2025.
-
Impressions And Takeaways From BPI West 2025
3/27/2025
Editor Tyler Menichiello reviews the most compelling topics and sessions from this year's BioProcess International U.S. West.
-
Areas For Advancement In Peptide Manufacturing
2/27/2025
Experts from Eli Lilly, NervGen, and Piramal Pharma Solutions discuss the myriad of ways peptide manufacturing can be improved, drawing on years of industry experience and insight.
-
For Gilead, Sustainability Is More Than A PR Effort
2/14/2025
Gilead's chief sustainability officer and SVP of operations, Joydeep Ganguly, explains the company's cultural focus on sustainability and how it influences everything from R&D to manufacturing.
-
GlycoNex On Challenges In Biosimilar Development, Manufacturing
1/29/2025
In this written Q&A, GlycoNex president and CEO, Dr. Mei-Chun Yang, shares insight into the company's development of its denosumab biosimilar, SPD8. She covers the company’s approach to analytics, cell line development, scaling, and more.
-
Easing Autologous Cell Collection, Automating Manufacturing
1/22/2025
To circumvent the challenges of leukapheresis, CellProthera developed a novel method for collecting therapeutic stem cells from whole blood. CSO Ibon Garitaonandia, Ph.D., discusses the company's mission to streamline manufacturing.